Protection Induced by Vaccination with Recombinant Baculovirus and Virus-like Particles Expressing <i>Toxoplasma gondii</i> Rhoptry Protein 18

Protection Induced by Vaccination with Recombinant Baculovirus and Virus-like Particles Expressing <i>Toxoplasma gondii</i> Rhoptry Protein 18

Heterologous immunization is garnering attention as a promising strategy to improve vaccine efficacy. Vaccines based on recombinant baculovirus (rBV) and virus-like particle (VLP) are safe for use, but heterologous immunization studies incorporating these two vaccine platforms remain unreported to d...

Full description

Bibliographic Details
Main Authors: Keon-Woong Yoon, Ki-Back Chu, Hae-Ji Kang, Min-Ju Kim, Gi-Deok Eom, Jie Mao, Su-Hwa Lee, Md Atique Ahmed, Fu-Shi Quan
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Vaccines
Subjects:
baculovirus
virus-like particle
<i>Toxoplasma gondii</i>
ROP18
vaccine
Online Access:https://www.mdpi.com/2076-393X/10/10/1588

Similar Items

Similar Items